These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1822770)

  • 1. Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities.
    Hajarizadeh H; Mueller CR; Woltering EA; Small K; Fletcher WS
    Melanoma Res; 1991; 1(1):55-61. PubMed ID: 1822770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
    Ariyan S; Poo WJ; Bolognia J
    Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities.
    Pommier RF; Moseley HS; Cohen J; Huang CS; Townsend R; Fletcher WS
    Am J Surg; 1988 May; 155(5):667-71. PubMed ID: 3369621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
    Fletcher WS; Woltering EA; Moseley HS; Bos G; Lebredo L; Brown D; Small K
    Cancer Treat Res; 1993; 62():241-4. PubMed ID: 8096739
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.
    Bryant PJ; Balderson GA; Mead P; Egerton WS
    World J Surg; 1995; 19(3):363-8. PubMed ID: 7638989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment.
    Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J
    Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value?].
    Meyer T; Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1452-4. PubMed ID: 9931909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents.
    Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis WJ; van der Weele LT
    Cancer; 1989 Jan; 63(1):199-203. PubMed ID: 2910418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
    Loescher LJ; Leigh S
    Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
    Fletcher WS; Pommier R; Small K
    Melanoma Res; 1994 Mar; 4 Suppl 1():17-9. PubMed ID: 8038590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated limb perfusion for recurrent melanoma of the extremity.
    Reintgen DS; Cruse CW; Wells KE; Saba HI; Slingluff CL
    Ann Plast Surg; 1992 Jan; 28(1):50-4. PubMed ID: 1642406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard.
    Hartley JW; Fletcher WS
    J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.